Masaaki Kawano
Saitama Medical University.Japan
Biography
Masaaki Kawano has been engaged in the study of the in vitro assembly of simian virus 40 (SV40) virus-like particles (VLPs) composed of VP1 capsid for 10 years, from the beginning of his career. He has currently focused on the development of a novel vaccine carrier consisting of SV40 VP1 for cytotoxic T lymphocyte (CTL)-based vaccines against latent infection and cancer
Abstract
Abstract : Medical application of a nanocapsule derived from a viral capsid protein
